Illuccix psma vasd
Ended Awarded Last action
- Contract number
- 36C26225F0243
- Awardee
-
Telix Pharmaceuticals US Inc. UEI NMRHMBK4YTH7
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $538,575
Award facts
- Opportunity
-
- 6505--illuccix psma vasd Special Notice · 36C26225Q0343 · Posted Jan 13, 2025
- Contract value 100% obligated
- $538,575.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$128,225 | |
| Supplemental Agreement for work within scope | $234,500 | |
| Supplemental Agreement for work within scope | $115,500 | |
| Original award | $316,800 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a $538.6K firm fixed-price delivery order to Telix Pharmaceuticals US Inc. on February 11, 2025, for the procurement of Illuccix, a specialized radiopharmaceutical product used for prostate cancer imaging in nuclear medicine applications. The delivery order, which carries no small business set-aside designation, is scheduled for completion by February 11, 2026, and will be performed in Dublin, Ohio. This award represents a call order against Telix Pharmaceuticals' larger Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB), which enables VA medical centers to procure specialized radiopharmaceutical products through pre-negotiated pricing terms.
Telix Pharmaceuticals US Inc., headquartered in Fishers, Indiana, is a global biopharmaceutical company that specializes in developing and supplying advanced diagnostic radiopharmaceuticals for nuclear medicine and medical imaging. The company has established itself as a primary supplier to the VA healthcare system across multiple Veterans Integrated Service Networks, holding multiple contract vehicles including a $17.5 million blanket purchase agreement for Illuccix procurement through August 2026. This delivery order supports the VA's nuclear medicine and medical imaging services for veteran healthcare and reflects the company's ongoing commitment to providing specialized diagnostic products across the federal government.
Quick answers
Who was awarded contract 36C26225F0243?
36C26225F0243 was awarded to Telix Pharmaceuticals US Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on February 11, 2025.
How much is contract 36C26225F0243 worth?
The government has obligated $538,575 on 36C26225F0243.
Is contract 36C26225F0243 an order under another contract?
Yes. 36C26225F0243 is a delivery order under 36F79722D0197, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26225F0243 competed?
The extent of competition for 36C26225F0243 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award